Recombinant multi-species GNAT1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GNAT1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Transducin is a 3-subunit guanine nucleotide-binding protein (G protein) which stimulates the coupling of rhodopsin and cGMP-phoshodiesterase during visual impulses. The transducin alpha subunits in rods and cones are encoded by separate genes. This gene encodes the alpha subunit in rods. This gene is also expressed in other cells, and has been implicated in bitter taste transduction in rat taste cells. Mutations in this gene result in autosomal dominant congenital stationary night blindness. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Feb 2009]
The Alternative Names of target: CSNB1G,CSNBAD3,GBT1,GNAT1,GNATR,Gnat-1,Gnat1,Guanine nucleotide-binding protein G(t) subunit alpha-1,HG1F,Hg1f,Ird1,Ird2,Tralpha,Transducin alpha-1 chain,irdc,irdr,transducin

Target products collectionGo to GNAT1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP7525-Ag-1/ GM-Tg-hg-IP7525-Ag-2 Human GNAT1 protein Human
GM-Tg-rg-IP7525-Ag-1/ GM-Tg-rg-IP7525-Ag-2 Rat GNAT1 protein Rat
GM-Tg-mg-IP7525-Ag-1/ GM-Tg-mg-IP7525-Ag-2 Mouse GNAT1 protein Mouse
GM-Tg-cynog-IP7525-Ag-1/ GM-Tg-cynog-IP7525-Ag-2 Cynomolgus/Rhesus macaque GNAT1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP7525-Ag-1/ GM-Tg-felg-IP7525-Ag-2 Feline GNAT1 protein Feline
GM-Tg-cang-IP7525-Ag-1/ GM-Tg-cang-IP7525-Ag-2 Canine GNAT1 protein Canine
GM-Tg-bovg-IP7525-Ag-1/ GM-Tg-bovg-IP7525-Ag-2 Bovine GNAT1 protein Bovine
GM-Tg-equg-IP7525-Ag-1/ GM-Tg-equg-IP7525-Ag-2 Equine GNAT1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP7525-Ag-1/ GM-Tg-hg-IP7525-Ag-2; GM-Tg-rg-IP7525-Ag-1/ GM-Tg-rg-IP7525-Ag-2;
GM-Tg-mg-IP7525-Ag-1/ GM-Tg-mg-IP7525-Ag-2; GM-Tg-cynog-IP7525-Ag-1/ GM-Tg-cynog-IP7525-Ag-2;
GM-Tg-felg-IP7525-Ag-1/ GM-Tg-felg-IP7525-Ag-2; GM-Tg-cang-IP7525-Ag-1/ GM-Tg-cang-IP7525-Ag-2;
GM-Tg-bovg-IP7525-Ag-1/ GM-Tg-bovg-IP7525-Ag-2; GM-Tg-equg-IP7525-Ag-1/ GM-Tg-equg-IP7525-Ag-2
Products Name GNAT1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name GNAT1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GNAT1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.